News

Filter

Current filters:

Thalidomide

1 to 9 of 112 results

UK’s NICE backs use of thalidomide and bortezomib for multiple myeloma

03-06-2010

In draft guidance published yesterday, the UK’s National Institute for Health and Clinical Excellence…

CelgeneEuropeJanssen-CilagJohnson & JohnsonOncologyPharmaceuticalRegulationThalidomideVelcade

Celgene falls up to 17% on low 1st-qtr forecast

03-04-2009

Shares in Celgene fell up to 17% on April 1, after the US drugmaker reported preliminary first-quarter…

Amino AcidsAzacitidineInjectionlenalidomidePhysostigmine SalicylateRevlimidThalidomideThalomidVidaza

Zolinza/Velcade combo enters Ph IIb MM trial

26-01-2009

The Multiple Myeloma Research Consortium has initiated a Phase IIb study of Merck & Co's Zolinza (vorinostat),…

bortezomiblenalidomideMerck KGaANystatinOralRevlimidThalidomideThalomidVelcadevorinostatZolinza

1 to 9 of 112 results

COMPANY SPOTLIGHT

Menarini

Back to top